Epidermal growth factor receptor in the vesical urothelium of paraplegic and tetraplegic patients: An immunohistochemical study

Spinal Cord

Volumn 34, Issue 10, 1996, Pages 578-586

  Van Velzen, D ^a   Krishnan, K R ^b   Parsons, K F ^b   Soni, B M ^b   Fraser, M H ^b   Vaidyanathan, S ^b,c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Regional Spinal Injuries Centre   (United Kingdom)

^c DISTRICT GENERAL HOSPITAL   (United Kingdom)

Author keywords

Epidermal growth factor receptor (EGFR); Neuropathic bladder; Spinal cord injury; Vesical dysplasia and metaphasia; Vesical neoplasia; Vesical urothelial proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLADDER; BLADDER BIOPSY; CLINICAL ARTICLE; CYSTITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INTESTINE METAPLASIA; LYMPHOCYTIC INFILTRATION; MALE; PARAPLEGIA; PRIORITY JOURNAL; QUADRIPLEGIA; SQUAMOUS CELL METAPLASIA; UROTHELIUM;

EID: 0029857416     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sc.1996.103     Document Type: Article

References (24)

1. See WA. Commentary on growth factors: The bread-and-butter cytokines of urology. Journal of Urology 1994; 152: 1942.
2. Carpenter G, Cohen S. Epidermal growth factor. Minireview. The Journal of Biological Chemistry 1990; 265: 7709-7712.
3. Messing EM. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Research 1990; 50: 2530-2537.
4. Messing EM, Hanson P, Ulrich P, Erturk E. Epidermal growth factor - Interactions with normal and malignant urothelium: in vivo and in situ studies. Journal of Urology 1987; 138: 1329-1335.
5. van Velzen et al. Vesical urothelial proliferation in spinal cord injury patients: an immunohistochemical study of PCNA and MIB-1 labelling. Paraplegia 1995; 33: 523-529.
6. Duel BP, Freeman M, Atala A. Expression of heparin-binding epidermal growth factor-like factor mRNA in a new model of urothelial injury. Journal of Urology 1995; 153: 265A.
7. Freeman MR et al. Human urothelial cells secrete and are regulated by heparin-binding epidermal growth factor-like factor. Journal of Urology 1995; 153: 307A.
8. Tobin MS et al. Growth factor biology of human uroepithelial cells grown under serum-free conditions. Journal of Urology 1995; 153: 406A.
9. Bejany DE, Lockhart JL, Rhamy RK. Malignant vesical tumours following spinal cord injury. Journal of Urology 1987; 138: 1390-1392.
10. Dougall WC et al. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 1994; 9: 2109-2123.
11. Modjtahedi H et al. Antitumour activity of combination of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor. Cell Biophys 1993; 22: 129-146.
12. Dong Z, Fidler I, Dinney C. Bladder cancer growth inhibition by epidermal growth factor receptor tyrosine kinase inhibitors. Journal of Urology 1994; 151: 392A.
13. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267: 1782-1788.
14. Yi ES et al. Keratinocyte growth factor causes proliferation of urothelium in vivo. Journal of Urology 1995; 154: 1566-1570.
15. Gibbs JB, Oliff A. Pharmaceutical research in molecular oncology. Cell 1994; 79: 193-198.
16. Grizzle WE, Myers RB, Arnold MM, Srivastava S. Evaluation of biomarkers in breast and prostate cancer. Journal of Cellular Biochemistry, Supplement 1994; 19: 259-266.
17. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 1987; 56: 881-914.
18. Yamaguchi K, Carr BI, Nalesnik MA. Concomitant and isolated expression of TGF-alpha and EGF-R in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma. J Surg Oncol 1995; 58: 240-245.
19. Suarez-Quian CA, Byers SW. Redistribution of epidermal growth factor receptor as a function of cell density, cell-cell adhesion and calcium in human (A-431) cells. Tissue-Cell 1993; 25: 1-17.
20. Oguey D, Reichen J, Marti U. Differential effect of micronodular and biliary cirrhosis on epidermal growth factor receptor expression in the rat. Journal of Hepatology 1994; 21: 997-1005.
21. Hobert M, Carlin C. Cytoplasmic juxtamembrane domain of the human EGF receptor is required for basolateral localization in MDCK cells. J Cell Physiol 1995; 162: 434-446.
22. Zschiesche W, Schonborn I, Minguillon C, Spitzer E. Significance of immunohistochemical c-erbB-2 product localization pattern for prognosis of primary human breast cancer. Cancer-Lett 1994; 81: 89-94.
23. Sorscher SM, Green MR, Feramisco JR. Enhanced E-cadherin expression in epidermal growth factor receptor expressing cells. Biochemical and Biophysical Research Communications 1995; 206: 518-524.
24. Good MJ et al. Localization and quantification of epidermal growth factor receptors on single cells by confocal laser scanning microscopy. The Journal of Histochemistry and Cytochemistry 1992; 40: 1353-1361.